Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.
19h
MedPage Today on MSNAlzheimer's Patients May Gain Months of Independent Living With TreatmentAlzheimer's patients with a baseline CDR-SB score of 3.5 could expect approximately 4 additional months (95% CI 2-7 months) ...
5h
Daily Express US on MSNScientists issue chilling warning over 'common' injury that could 'double' dementia riskAn injury that is often overlooked by many could actually double your risk of developing dementia, according to a stark new ...
Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...
Existing, approved medicines could offer a shortcut to future treatments. (MirageC/Getty Images) This led them to the ...
Clinical Dementia Rating (CDR) scores can help doctors tell when people with Alzheimer’s disease experience lower ...
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
Physical changes in the brain are responsible for dementia, which is a progressive condition. As the symptoms become more severe, a person will need different treatment and care. Medicare helps ...
Researchers investigated cerebral small vessel disease, a precursor to dementia, by analyzing data from thousands of ...
Experts say early intervention is key to treating and coping with dementia or Alzheimer's. Here's what to keep an eye out for ...
Scientists say people who have experienced a brain bleed should be regularly screened for cognitive impairment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results